Join our expert webinar to discuss some of the critical issues affecting covered entities now and in the future. In this session, panelists will - Share key insights from Pharma restrictions and 340B state litigation - Provide updates on 340B program transparency discussions - Review recent HRSA compliance audit experience related to referral capture Speakers: Melissa Opraseuth, PharmD SVP 340B Operations, R1 Bryan Murray, JD Partner, Dinsmore & Shohl, LLP

Join us for an insightful fireside chat with Eric Manuel Balmir, Vice President of Clinical Ancillary Services & Chief Pharmacy Officer at Children’s National Hospital, Ted Slafsky, Publisher & CEO of 340B Report, and Lauren Forni, Senior Director of Clinical Strategy at Bluesight. Together, they will provide the latest updates with the 340B program and explore key strategies to build and sustain a successful program while ensuring compliance in an ever-changing regulatory landscape.